Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.1 USD | 0.00% | -2.65% | -10.20% |
May. 16 | HCW Biologics Inc. announced that it expects to receive $10 million in funding | CI |
Apr. 01 | HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 41.61M |
---|---|---|---|---|---|
Net income 2024 * | -23M | Net income 2025 * | -29M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.93
x | P/E ratio 2025 * |
-2
x | Employees | 45 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.19% |
1 week | -2.65% | ||
Current month | -21.43% | ||
1 month | -28.10% | ||
3 months | -6.38% | ||
6 months | +0.46% | ||
Current year | -10.20% |
Managers | Title | Age | Since |
---|---|---|---|
Hing Wong
FOU | Founder | 70 | 18-04-01 |
Rebecca Byam
DFI | Director of Finance/CFO | 68 | 19-09-30 |
Peter Rhode
CTO | Chief Tech/Sci/R&D Officer | 66 | 19-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Garrett
CHM | Chairman | 73 | 21-04-30 |
Hing Wong
FOU | Founder | 70 | 18-04-01 |
Rick Greene
BRD | Director/Board Member | 59 | 21-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1.1 | 0.00% | 20,538 |
24-05-16 | 1.1 | -5.17% | 121,983 |
24-05-15 | 1.16 | +0.87% | 46,199 |
24-05-14 | 1.15 | +2.68% | 13,996 |
24-05-13 | 1.12 | -0.88% | 25,591 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.20% | 41.61M | |
+9.42% | 115B | |
+11.84% | 106B | |
-2.33% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- HCWB Stock